Rhenman Healthcare Equity L/S awarded international prize for Long Term Performance – Equity Strategies (5 Years) at EuroHedge Awards in London
The first Nordic fund to receive this award
The fund returned +245% during the five-year period (+28% annualised)
Since inception in June 2009, the fund has returned a total of +323%
The sector fund Rhenman Healthcare Equity L/S was awarded Long Term Performance – Equity Strategies (5 Years) at the prestigious EuroHedge Awards in London. The prize refers to the period 2011-2015 and was awarded by Goldman Sachs.
"We are extremely pleased to receive this award. This is the most respected international prize in Europe for hedge funds, which demonstrates our ability to generate substantial long-term value for our investors. To be the best hedge fund over five years says more than to win it based on performance for a single year. This is the first time that a Nordic fund has achieved this”, said Carl Grevelius, Head of Investor Relations and Founding Partner.
"Our success depends largely on the managers’ close collaboration with the medical experts in our Scientific Advisory Board. Equally important is our focus on the healthcare sector, including pharmaceuticals, medical technology, biotechnology and service, which gives us a vast number of investment opportunities to choose from."
Rhenman Healthcare Equity L/S is a global healthcare-focused hedge fund that is part of SEB Fund Services S.A. Luxembourg’s umbrella fund, with Rhenman & Partners Asset Management AB acting as portfolio manager.
The Fund has an unprecedented return history since the inception in June 2009. The main fund class, the IC1 (EUR), has risen 323% in total, corresponding to an average annual return of +25%. In 2015, the return was +20%. In accordance with the fund prospectus, the fund was closed to investments from new investors on 31 December 2015 when total assets under management reached €500m.
For more information, please contact:
Carl Grevelius, Founding Partner / Head of Investor Relations
Phone: +46 8 459 88 83
E-mail: carl@rhepa.com
www.rhepa.com
About Rhenman & Partners
Rhenman & Partners Asset Management is a Stockholm-based asset manager focusing on the healthcare sector. The company's AUM amount to over EUR 530m. Rhenman & Partners was founded in 2008 by a trio with extensive experience of the asset management sector, as well as an unrivalled track record in the healthcare sector. Henrik Rhenman has over 20 years’ experience of managing successful healthcare funds.
The Rhenman Healthcare Equity L/S fund is unique in that it is supported by a Scientific Advisory Board composed of eminent professors, each with over 30 years in their field. The Group has access to a wide network of scientists and experts at several recognized institutions worldwide, including the Karolinska Institute.
The fund has a long term investment horizon and a diversified portfolio of around 60-80 core positions. Whilst trading around positions the fund remains diversified across subsectors, company size and geographies to lower volatility.
For more information, please visit www.rhepa.com
Tags: